vasopressin analogue

Desmopressin

US: FDA-approvedEU: Not on the registerUK: AuthorisedCA: AuthorisedAU: RegisteredCH: AuthorisedBR: RegistadoRS: AuthorisedSG: RegisteredTR: Ruhsatli

Answer

Desmopressin is authorised or registered in the US, the UK, Canada, Australia, Switzerland, Brazil, Serbia, Singapore and Turkey: 9 of the 10 registers read. Highest trial phase: Phase 4 (after approval). It has 131 registered trials, 16 of them running. Brand names on the FDA label register: Desmopressin Acetate, Desmoda, Ddavp and Stimate.

RegulatorTrial register10 regulators' registers, read 2026-08-31 to 2026-10-03 · ClinicalTrials.gov and EU CTIS, read 2026-10-03

Not medical, legal or regulatory advice.

Registered trials131Trial register ClinicalTrials.gov and EU CTIS
Running now16Trial register recruiting, active or enrolling
Results posted16Trial register with results on the register
Stopped early9.2%Trial register all peptides: 10%

131 trials by status

Trial register
Running 16Completed 77Stopped early 12Status unknown 22Other or not stated 4

ClinicalTrials.gov and EU CTIS · read 2026-10-03 · 16 trials have posted results

Trials first submitted per year

Trial register

ClinicalTrials.gov first-submitted date, last 10 years · read 2026-10-03. 2026 is not complete. 77 trials carry no first-submitted date (EU CTIS publishes none, or the year is outside this range).

Status by jurisdiction

World map
Authorised or registeredNot on the register, or withdrawnNot read yet, or status unknown
WhereStatusRegisterRead
United StatesFDA-approvedFDA, openfda2026-10-03
European UnionNot on the registerEMA, ema2026-08-31
United KingdomAuthorisedMHRA, uk-mhra2026-10-03
CanadaAuthorisedHealth Canada, ca-dpd2026-10-03
AustraliaRegisteredTGA, au-artg2026-10-03
SwitzerlandAuthorisedSwissmedic, ch-swissmedic2026-10-03
BrazilRegistadoANVISA, br-anvisa2026-10-03
SerbiaAuthorisedALIMS, rs-alims2026-09-03
SingaporeRegisteredHSA, sg-hsa2026-09-03
TurkeyRuhsatliTITCK, tr-titck2026-09-03

An EU decision applies in the 30 territories the EU register covers: its member states, and Iceland, Liechtenstein and Norway. A dashed tile has no register read for this peptide.

Side effects

Trial register
8 placebo-controlled trials · 2,891 people on Desmopressin · grey is placebo
Headache7% 3.9%
Nausea4.9% 1.3%
Diarrhoea4.7% 2.2%
Nasopharyngitis4.2% 3.1%
Hypertension3.3% 0.7%
ClinicalTrials.gov posted results · read 2026-10-03All side effects

CHANGE ALERTS

Get an email when this changes

One email when the status of Desmopressin changes on the register. You confirm your address first.

REGISTERED TRIALS

Newest 10 of 131 trials

All 131 trials
NCT07855315
FESS With or Without Intranasal Desmopressin in Chronic Rhinosinusitis With Nasal Polyps
not yet recruiting participants · register updated 2026-10-02
NCT07840313
Prophylactic Desmopressin Before Native Kidney Biopsy in Severe Renal Impairment
completed · register updated 2026-09-25
NCT07179991
DDAVP Effect by TEG6 in Cardiac Surgery
currently recruiting participants · register updated 2026-09-21
NCT06635629
Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome
currently recruiting participants · register updated 2026-08-31
NCT07576036
International Multi-center Retrospective Study of Patients With Serum Sodium ≤110 mmol/L to Determine the Relationship Between Osm
enrolling by invitation only · register updated 2026-08-26
NCT07776977
Bedtime Device Restriction and Desmopressin in PMNE.
currently recruiting participants · register updated 2026-08-24
NCT07712328
Randomized Controlled Clinical Study on the Prophylactic Intraoperative Use of Desmopressin in Complex Sellar Region Tumors
enrolling by invitation only · register updated 2026-07-17
NCT06337838
Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial
currently recruiting participants · register updated 2026-05-22
NCT04569591
DDAVP for Pituitary Adenoma
currently recruiting participants · register updated 2026-04-09
NCT07292753
Vitamin D Versus Desmopressin Versus Combination Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis and Vitamin D
completed · register updated 2026-03-17

All peptides · Method

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.